Silencing of Lysyl Oxidase Gene Expression by RNA Interference Suppresses Metastasis of Breast Cancer |
Liu, Jian-Lun
(Department of Breast Surgery, Cancer Hospital, Guangxi Medical University)
Wei, Wei (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) Tang, Wei (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) Jiang, Yi (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) Yang, Hua-Wei (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) Li, Jing-Tao (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) Zhou, Xiao (Department of Breast Surgery, Cancer Hospital, Guangxi Medical University) |
1 | Payne SL, Angela R. Hess AR, et al (2005). Lysyl oxidase facilitates intracellular signaling in invasive breast cancer cells. Proc Amer Assoc Cancer Res, 46, 67-8. |
2 | Peyrol S, Raccurt M, Gerard F, et al (1997). Lysy1 oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol, 150, 497-507. |
3 | Sulaiman S, Shahril MR, Shaharudin SH, et al (2011). Fat intake and its relationship with pre- and postmenopausal breast cancer risk: a case-control study in Malaysia. Asian Pac J Cancer Prev, 12, 2167-78. |
4 | Talvensaari MA, Paakko P, Turpeenniemi HT (2003). Matrix metalloproteinase-2 (MMP-2) is associated with sunixal in breast carcinoma. Br J Cancer, 89, 1270-5. DOI ScienceOn |
5 | Woznick AR, Braddock AL, Dulai M, et al (2005). Lysyl oxidase expression in bronchogenic carcinoma. Am J surg, 189, 297-301. DOI |
6 | Yu Q, Stamenkovic I (2000). Cell surface-localized matrixmetalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes, 14, 163-76. |
7 | Zucker S, Hymowitz M, Rollo EE, et al (2001). Tumorigenic potential of extracellar matrix metalloproteinase inducer. Am J Pathol, 158, 1921-8. DOI |
8 | Akiri G, Sabo E, Dafni H, et al (2003). Lysyl oxidase-related protein-1 promotes tumorfibrosis and tumor progression in vivo. Cancer Res, 63, 1657-66. |
9 | Erler JT, Bennewith KL, Nicolau M, et al (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440, 1222-6. DOI |
10 | Erler JT, Giaccia AJ (2006). Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res, 66, 10238-41. DOI |
11 | Fong SF, Dietzsch E, Fong KS, et al (2007). Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and asociated with lass differentiated colon turners. Genes Chromosomes Cancer, 46, 644-55. DOI |
12 | Hafez MM, Hassan ZK, Zekri AR, et al (2012). MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev, 13, 591-8. 과학기술학회마을 DOI |
13 | Kirschmann DA, Seftor EA, Fong SF, et al (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res, 62, 4478-83. |
14 | Holtmeier C, Gorogh T, Beier U, et al (2003). Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas. Anticancer Res, 23, 2585-91. |
15 | Jing DC, Blidaru A, Condrea I, et al (2006). MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors. J Cell Mol Med, 10, 499-510. DOI |
16 | Kirschmann DA, Payne SL, Seftor EA , et al (2005). Tumor suppressor gene Maspin and hypoxia inversely regulate lysyl oxidase facilitated breast cancer motility. Proc Amer Assoc Cancer Res, 46, 57-8. |
17 | Lhotak S, Elavathil LJ, Vukmirovic-Popovic, et al (2000). Immunolocalization of matrix- metallo-proteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma. Clin Exp Metastasis, 18, 463-70. DOI |
18 | Liotta LA, Steeg PA, Stetler-stevenson WG (1991). Canaer metastasis and angiogensis: and imbalance of positive negative regulation. Cell, 64, 327-31. DOI ScienceOn |
19 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods, 25, 402-8. DOI ScienceOn |
20 | Loh SY, Chew SL, Lee SY (2011). Physical Activity and Women with Breast Cancer: Insights from Expert Patients. Asian Pac J Cancer Prev, 12, 87-94. |
21 | Nakopoulou L, Katsarou S, Giannopoulou I, et al (2002). Correlation of tissue inhibitor of metalloproteinase- 2 with proliferative actixity and patients sunal in breast cancer. Mod Patho1, 15, 26-34. DOI |